Our previous studies showed inverse correlations between HER2 expression and HLA class I expression in several human tumors including melanoma, carcinoma, breast cancer, esophageal cancer, and gastric cancer (GC)12–15. This evidence concerns the gene ERBB2 and breast carcinoma.